| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This research service covers the U.S. alcohol dependence and abuse
pharmaceuticals market from 2003-2013. Included are patient forecasts and a
therapeutic overview. The market is segmented by product as follows: Antabuse,
Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints,
and strategic recommendations to overcome market challenges are also discussed.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 TOTAL MARKET
- Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Disease Overview
- Introduction
- Disease Definition
- Signs and Symptoms
- Risk Factors
- Diagnosis
- Treatment
- Health Risks of Excessive Alcohol Consumption
- Disease Statistics
- Patient Outlook
- General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
3 MARKETED THERAPIES OVERVIEW
- Overview
- Antabuse
- Campral
- ReVia
- Vivitrol
4 APPENDIX
- Decision Support Databases
- Road Accident Casualties
- Liver Cancer Cases
- Total Consumption of Alcohol
- Per Capita Consumption of Alcohol
- Hypertension Prevalence
|
